Pharmacy Blogs

… FDA Approves Intravenous Formulation Of Pfizer’s Revatio (Sildenafil) For The Treatment Of Pulmonary Arterial Hypertension NEW YORK – … announced today that the U.S. Food and Drug Administration (FDA) has approved Revatio (sildenafil) Injection, …
FDA Approves Intravenous Formulation Of Pfizer’s Revatio (Sildenafil) For The Treatment Of Pulmonary Arterial Hypertensi

Random Posts

• 1st shipment of H1N1 vaccine on the way
• Somaxon Pharmaceuticals to Report 2009 Third Quarter Financial Results and … – Reuters

Related posts:

1. European Commission Approves New Intravenous Formulation Of Pfizer’s Revatio (Sildenafil) For The Treatment Of Pulmonary Arterial Hypertension
2. FDA Approves Intravenous Formulation Of Pfizer’s Revatio(R) (Sildenafil) For The Treatment Of Pulmonary Arterial Hypertension Revatio is the Only Treatment in Its Class with Both Oral and Intravenous Formulations
3. European Commission Approves New Intravenous Formulation Of Pfizer’s Revatio(R) (Sildenafil) For The Treatment Of Pulmonary Arterial Hypertension Revatio is Only PAH Treatment in Its Class with Approved I.V. Formulation, Allowing